Literature DB >> 2874769

Serotoninergic mechanisms in human feeding: the pharmacological evidence.

T Silverstone, E Goodall.   

Abstract

This paper reviews the evidence of serotoninergic mechanisms in human feeding by considering the effects of 5-HT agonists, precursors and receptor antagonists on hunger, food intake and weight change in normal volunteers, obese people and psychiatric patients. Although there is compelling evidence for a serotonin (5-HT) mechanism being involved, the paper highlights the considerable individual variation in response to pharmacological manipulation of 5-HT. Such variation may reflect differences in the bio-availability of the drugs used. Subtle psychological factors may also play a role in blurring the pharmacological evidence for 5-HT involvement in the highly complex activity of human feeding.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874769     DOI: 10.1016/s0195-6663(86)80054-x

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  6 in total

1.  Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.

Authors:  G Hewson; G E Leighton; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

Review 2.  The role of serotonin in eating disorders.

Authors:  S F Leibowitz
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats.

Authors:  C T Dourish; M L Clark; A Fletcher; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  The anorectic effect of increasing doses of L-tryptophan in obese patients.

Authors:  H Cavaliere; G Medeiros-Neto
Journal:  Eat Weight Disord       Date:  1997-12       Impact factor: 4.652

5.  Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice.

Authors:  Samantha J Line; Christopher Barkus; Clare Coyle; Katie A Jennings; Robert M Deacon; Klaus P Lesch; Trevor Sharp; David M Bannerman
Journal:  Eur Neuropsychopharmacol       Date:  2010-09-22       Impact factor: 4.600

6.  Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder.

Authors:  Chih-Hsing Wu; Chin-Sung Chang; Yen Kuang Yang; Lie-Hang Shen; Wei-Jen Yao
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.